Core One Labs Announces Vocan Assembles Equipment to Produce Biosynthesized Psilocybin

Numinus Announces Listing of Warrants

Mydecine Innovations Group Included in First-Ever Psychedelics ETF

Havn Life Sciences Announces Inclusion in First Psychedelic Exchange Traded Fund

Entheon Biomedical to be Included in First North American Psychedelic ETF

Revive Therapeutics Included in First Psychedelic Exchange Traded Fund

Solactive Publishes North American Psychedelic Index, Underyler of Horizons $PSYK ETF

Mind Cure Health Inc. Announces an Increase to Previously Announced Bought Deal Public Offering

Psyched Wellness Upsizes Previously Announced Bought Deal Offering

Empower Clinics Doubling KAI Medical Laboratory Size In Anticipation Of Test Volumes By End Of Q1. Files MDEL Application With Health Canada To Import and Sell KAI Saliva PCR Test In Canada

Psyched Wellness Submits an Application to Register a Trademark for the Company's Unique Extraction

New Wave Welcomes Iman Nevab, Homeopathic Research Expert to the Scientific Advisory Board

Revive Therapeutics Announces Upsize to Previously Announced Bought Deal Offering

Canadian Military Veteran, Master Corporal Scott Atkinson, Submits Request to Minister of Health, Hon. Patty Hajdu, to Access Proven Psilocybin-Assisted Psychotherapy For Non-Palliative Use 

Psyence Group Inc Completes Reverse Takeover Transaction and Completes Non-brokered Financing

MINDCURE Included in First Psychedelic ETF & North American Psychedelics Index